These Analysts Increase Their Forecasts On Jabil After Q4 Results

Jabil Inc (NYSE: JBL) reported mixed fourth-quarter results and issued strong first-quarter earnings guidance.

Jabil Inc (NYSE:JBL) reported mixed fourth-quarter results and issued strong first-quarter earnings guidance.

Jabil reported quarterly revenue of $8.46 billion, missing the consensus estimate of $8.54 billion. The company’s adjusted EPS of $2.45 beat the consensus of $2.32.

Jabil sees first-quarter revenue of $8.4 billion-$9.0 billion vs. the consensus of $9.18 billion. The company sees adjusted EPS of $2.40-$2.80 vs. the consensus of $2.33.

Jabil shares gained 1.1% to trade at $126.31 on Friday.

These analysts made changes to their price targets on Jabil following earnings announcement.

  • Barclays increased the price target on Jabil from $134 to $144. Barclays analyst George Wang maintained an Overweight rating.
  • Stifel raised the price target on Jabil from $120 to $135. Stifel analyst Matthew Sheerin maintained a Buy rating.

Check This Out: Pinterest, Cloudflare And 2 Other Stocks Insiders Are Selling

Total
0
Shares
Related Posts
Read More

Biora Therapeutics Provides Guidance On Anticipated Milestones During 2024; Says We Begin 2024 In The Clinic With Our Phase 1 Study For BT-600, Which Will Be A Major De-Risking Step In The Development Of Our NaviCap Platform

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today provided guidance on anticipated milestones during 2024. "In 2023, we completed the transformation of

BIOR